Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value: $572M (100.0% shares, 0.0% debt)

Holdings (10)

IRWD IRONWOOD PHARMACEUTICALS INC 25.0%

Value $143M Shares 16,390,000 Est. Cost $11.52 Unrealized +5.4%

BIIB BIOGEN INC 24.3%

Value $139M Shares 643,000 Est. Cost $278.12 Unrealized -15.8%

INVA INNOVIVA INC 19.4%

Value $111M Shares 7,277,000 Est. Cost $13.02 Unrealized +20.7%

GILD GILEAD SCIENCES INC 14.1%

Value $80.82M Shares 1,103,282 Est. Cost $58.12 Unrealized +23.9%

NBIX NEUROCRINE BIOSCIENCES INC 8.4%

Value $47.78M Shares 346,426 Est. Cost $103.73 Unrealized +31.7%

— AMARIN CORP PLC 3.9%

Value $22.14M Shares 24,850,623 Est. Cost $1.48 Unrealized —

CYTK CYTOKINETICS INC 3.7%

Value $21.03M Shares 300,000 Est. Cost $77.34 Unrealized 0.0%

BCRX BIOCRYST PHARMACEUTICALS INC 1.0%

Value $5.558M Shares 1,094,168 Est. Cost $5.10 Unrealized +10.2%

— VOR BIOPHARMA INC 0.3%

Value $1.465M Shares 618,000 Est. Cost $43.10 Unrealized —

— REGULUS THERAPEUTICS INC 0.1%

Value $533K Shares 185,183 Est. Cost $2.07 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$143M	25.0%	$11.52	+5.4%	COM CL A	46333X108
BIIB	BIOGEN INC	643,000	$139M	24.3%	$278.12	-15.8%	COM	09062X103
INVA	INNOVIVA INC	7,277,000	$111M	19.4%	$13.02	+20.7%	COM	45781M101
GILD	GILEAD SCIENCES INC	1,103,282	$80.82M	14.1%	$58.12	+23.9%	COM	375558103
NBIX	NEUROCRINE BIOSCIENCES INC	346,426	$47.78M	8.4%	$103.73	+31.7%	COM	64125C109
—	AMARIN CORP PLC	24,850,623	$22.14M	3.9%	$1.48	—	SPONS ADR NEW	023111206
CYTK	CYTOKINETICS INC	300,000	$21.03M	3.7%	$77.34	0.0%	COM NEW	23282W605
BCRX	BIOCRYST PHARMACEUTICALS INC	1,094,168	$5.558M	1.0%	$5.10	+10.2%	COM	09058V103
—	VOR BIOPHARMA INC	618,000	$1.465M	0.3%	$43.10	—	COM	929033108
—	REGULUS THERAPEUTICS INC	185,183	$533K	0.1%	$2.07	—	COM	75915K309